BCAS4 antibody (N-Term)
Quick Overview for BCAS4 antibody (N-Term) (ABIN499425)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- BCAS4 antibody was raised against a 14 amino acid peptide near the amino terminus of human BCAS4.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA. Western Blot: BCAS4 antibody can be used for detection of BCAS4 at 1 - 2 μg/mL. Immunohistochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
- BCAS4 (Breast Carcinoma Amplified Sequence 4 (BCAS4))
-
Alternative Name
- BCAS4
-
Background
- The Breast carcinoma amplified sequence (BCAS4) gene is localized to 20q13, a region that is often amplified in breast cancers. It was isolated by the cloning of a highly overexpressed 1.3 kb transcript from the fusion of the last two exons of the BCAS3 and BCAS4 genes. This BCAS3-BCAS4 fusion transcript is only found in the MCF7 cell line, but the BCAS4 gene is also overexpressed in nine of thirteen breast cancer cell lines. The role of BCAS4 is unknown but its mRNA is highly expressed in thymus, spleen, kidney, brain, and placenta, suggesting BCAS4 plays other roles in multiple tissues.Synonyms: Breast carcinoma-amplified sequence 4
-
Gene ID
- 55653
-
UniProt
- Q8TDM0
Target
-